Pleckstrin serves as a prognostic marker for COVID-19 and promotes lung injury via ERK activation
Acta Pharmaceutica Sinica B · 2026-11
DOI: 10.1016/j.apsb.2026.11.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Li Zhong und 9 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhong, L., Zhou, R., Zhu, L., Yan, H., Yuan, S., To, K. K., Liu, N., Wang, P., Chen, Z., & Cai, Z. (2026). Pleckstrin serves as a prognostic marker for COVID-19 and promotes lung injury via ERK activation. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.11.014
Vancouver
Zhong L, Zhou R, Zhu L, Yan H, Yuan S, To KK, et al. Pleckstrin serves as a prognostic marker for COVID-19 and promotes lung injury via ERK activation. Acta Pharmaceutica Sinica B. 2026. doi:10.1016/j.apsb.2026.11.014
BibTeX
@article{Zhong2026,
author = {Zhong, Li and Zhou, Runhong and Zhu, Lin and Yan, Hong and Yuan, Shuofeng and To, Kelvin Kai-Wang and Liu, Na and Wang, Pui and Chen, Zhiwei and Cai, Zongwei},
title = {Pleckstrin serves as a prognostic marker for COVID-19 and promotes lung injury via ERK activation},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
doi = {10.1016/j.apsb.2026.11.014}
}
EUVIMED